Ionotropic receptors

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:14, 22 January 2023) (edit) (undo)
 
(11 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='3kg2' size='350' side='right' scene='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Default3kg2/1' caption='The rat glycosylated glutamate receptor in complex with a competitive antagonist ([[3kg2]])'>
+
<StructureSection load='3kg2' size='300' side='right' scene='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Default3kg2/1' caption='The rat glycosylated glutamate receptor in complex with a competitive antagonist ([[3kg2]])'>
-
'''Under development!!!'''
+
See also [[Receptor]].
-
 
+
=Cys-loop receptors=
=Cys-loop receptors=
Line 8: Line 7:
===Serotonin type-3 receptor (5-HT3-R)===
===Serotonin type-3 receptor (5-HT3-R)===
*[[5-hydroxytryptamine receptor#Structural highlights/Specific Function of 5-HT3]]
*[[5-hydroxytryptamine receptor#Structural highlights/Specific Function of 5-HT3]]
 +
<scene name='71/716548/5-ht3_receptor/1'>The 5-HT3 receptor</scene> is a pentameric cation-selective ion channel and plays a role in neuronal excitation to release neurotransmitters from the postsynaptic neuron. Opening of the cation channel causes an influx of sodium and calcium through the receptor pore leading to a membrane depolarization. Five receptor subunits, A to E, have been found in humans but only subunits A and B have been found in rodents. When experimentally expressed in a host, the 5-HT3 receptor is comprised of either A or AB subunits which can result in a homopentameric receptor or a heteropentameric receptor respectively. The A and B subunits are found throughout the brain in areas such as the hippocampus and amygdala. 5-HT3 is a transmembrane channel that is stimulated to open state by the interaction of the receptor with serotonin in the extracellular space. The binding site is comprised of 6 loops from 2 adjacent subunits in the extracellular N-terminal domain. Loops A, B and C form the principal subunit and contain the <scene name='71/716548/5-ht3/1'>important side chains</scene> N128, W183 and Y234. Loops D, E and F form the complementary subunit of the binding site and contain the important side chains W90, Y143 and W195. The transmembrane region is comprised of multiple alpha helical structures and mediates ion flow and ion specificity.
 +
*[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref>
*[[Journal:JBSD:16|The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study]]<ref>DOI 10.1080/07391102.2012.680029</ref>
Line 18: Line 19:
*[[5-hydroxytryptamine receptor#5-HT3 receptor antagonists]]
*[[5-hydroxytryptamine receptor#5-HT3 receptor antagonists]]
====[[5-ht3a receptor|5-HT3A receptor]]====
====[[5-ht3a receptor|5-HT3A receptor]]====
-
 
+
The <scene name='71/716487/Default/1'>5-HT3</scene> receptor is bullet-shaped and consists of 5 subunits (A-E) that form an oligomer. In the center of this pentamer of is a ligand-gated ion channel full of water, which the 5 subunits enclose pseudo-symmetrically. Each subunit of the 5-HT3 receptor consists of 3 regions; the extracellular region, the transmembrane region, and the intracellular region. The <scene name='71/716487/Extracellular_region/1'>extracellular region</scene> is relatively large compared to the other 2 regions, and contains a short C-terminus and a larger N-terminus. The N-terminus of the extracellular region is where the ligand binding occurs, and therefore deals with the agonists and antagonists. These <scene name='71/716487/Binding_site/4'>binding sites</scene> are located between 2 bordering subunits, assembled from 3 α-helices of 1 subunit and 3 β-strands from the other subunit. Such connection creates a binding pocket with a small number of residues from each subunit pointed into the binding pocket, as opposed to the large number of residues that are pointing <scene name='71/716487/Default/11'>away</scene> from the binding pocket. This binding pocket shrinks around agonists, encapsulating them, and widens around antagonists, repulsing them. The <scene name='71/716487/Default/5'>transmembrane region</scene> is within the C-terminus region, and contains 4 α-helical domains (M1-M4) that stretch the length of this inner, transmembrane area. These 4 α-helical domains conduct the channel openings via ion selectivity, depending on both charge and size. M2, the porous domain, contains rings of charged amino acids at both its start and its <scene name='71/716487/Default/10'>end</scene>, accounting for M2 main contribution to ion selectivity. The M3 and M4 α-helices create a large <scene name='71/716487/Default/6'>loop</scene> with one another, thus assembling the <scene name='71/716487/Default/7'>intracellular region</scene>.
===Nicotinic acetylcholine receptors===
===Nicotinic acetylcholine receptors===
*[[Nicotinic Acetylcholine Receptor|Nicotinic Acetylcholine Receptors in general]]
*[[Nicotinic Acetylcholine Receptor|Nicotinic Acetylcholine Receptors in general]]
-
*[[Alpha-bungarotoxin]] is a nicotinic cholinergic antagonist that is found within the venom of ''Bungarus multicinctus'', a South-asian snake belonging to a group commonly known as kraits.
+
The receptor is a transmembrane pentameric glycoprotein. It cylindrical in appearance by electron microscopy approximately 16nm in length and 8nm in diameter. The main ion channel is composed of a water pore that runs through the entire length of the protein. If viewed from the synaptic cleft, the protein will look like a pseudo-symmetrical rosette shown in the picture below composed of 10 different alpha and 4 different beta subunits.
 +
*<scene name='58/584302/Cv/1'>Side view</scene>.
 +
*<scene name='58/584302/Cv/2'>View from extracellular side</scene>.
 +
*<scene name='58/584302/Cv/3'>View from cytoplasmic side</scene>.
 +
 
 +
*[[Alpha-bungarotoxin]] is a nicotinic cholinergic antagonist that is found within the venom of ''Bungarus multicinctus'', a South-asian snake.
*[[Binding site of AChR]]
*[[Binding site of AChR]]
*[[Acetylcholine Receptor and its Reaction to Cobra Venom]]
*[[Acetylcholine Receptor and its Reaction to Cobra Venom]]
 +
When cobra venom is introduced into the body is moves along the bloodstream to a diaphragm muscle. It works as a postsynaptic neurotoxin binding to the receptor as an extracellular ligand by interacting with OH group leaving the acetylcholine channel open which releases ions used in creating an action potential. There must be 5 molecules of cobra toxin (red) to block the receptor (blue) as each molecule binds with an individual alpha chain on the acetylcholine receptor. The 2nd image depicts an individual toxin binding with one chain on the receptor, both in the same color. <scene name='77/778333/Cobra_snake_venom/3'>Cobra Venom Interaction with Acetylcholine Receptor</scene>. This representation shows each molecule of the <scene name='77/778333/Venom_receptor_piece/1'>Cobra toxin binding to one chain of the receptor</scene>.
==Anionic cys-loop receptors==
==Anionic cys-loop receptors==
===GABA<sub>A</sub> receptors===
===GABA<sub>A</sub> receptors===
-
*[[4cof]] – hGABAA subunit β-3 - human<br />
+
 
-
*[[6i53]], [[6hup]], [[6huo]], [[6huk]], [[6huj]], [[6hug]] – hGABAA subunits β-3 + α-1+γ-2 + megabody – Cryo EM<br />
+
See [[GABAA receptor]]
-
*[[6d6u]], [[6d6t]] – hGABAA subunits β-3 +α-1+γ-2 + antibody + GABA + flumazenil – Cryo EM<br />
+
-
*[[6a96]] – hGABAA subunits β-3 +α-5 + nanobody + GABA – Cryo EM<br />
+
-
*[[6hsn]] – rGABAA subunit α-3 + gephyrin + ADP - rat<br />
+
-
*[[6dw1]], [[6dw0]] – rGABAA subunits β-1 +α-1+γ-2 + GABA – Cryo EM<br />
+
=[[Ionotropic Glutamate Receptors]]=
=[[Ionotropic Glutamate Receptors]]=
==AMPA glutamate receptor==
==AMPA glutamate receptor==
*[[Molecular Playground/Glutamate Receptor|AMPA glutamate receptor]] by [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].
*[[Molecular Playground/Glutamate Receptor|AMPA glutamate receptor]] by [http://www.umass.edu/cbi/ University of Massachusetts Amherst Chemistry-Biology Interface Program] at UMass Amherst and on display at the [http://www.molecularplayground.org/ Molecular Playground].
 +
Full view of the glutamate receptor shows the overall structure (N-terminal, ligand-binding and transmembrane domains) in <scene name='User:Mariel_Feliciano/sandbox_1/Full_view_black_background/6'>ribbon</scene> and <scene name='User:Mariel_Feliciano/sandbox_1/Full_view_spacefill/2'>spacefilling</scene> models. <scene name='User:Mariel_Feliciano/sandbox_1/Amino_terminal_domains/2'>N-terminal domain</scene> is a part of the extracellular domain. This domain is implicated in receptor assembly, trafficking, and localization.
 +
*<scene name='Molecular_Playground/Glutamate_Receptor/Transmembrane_domains/5'>Transmembrane Domain</scene>.
 +
*<scene name='Molecular_Playground/Glutamate_Receptor/Transmembrane_domains_pore2/1'>Transmembrane Domain, other representaion</scene>. This domain widens in response to glutamate binding allowing for positive ions to pass through the post-synaptic membrane.
 +
*<scene name='Molecular_Playground/Glutamate_Receptor/Glu_antagoinist/2'>Receptor antagonist 2K200225 binding site</scene>.
 +
*<scene name='Molecular_Playground/Glutamate_Receptor/Glu_agonist_/2'>Glutamate binding site</scene>.
*[[Glutamate receptor (GluA2)]]
*[[Glutamate receptor (GluA2)]]
 +
The homomeric rat GluA2 receptor <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Default3kg2/1'>has 4 subunits</scene> arranged in a 'Y'-shape with the <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Meas3kg2/1'> 'top' being about 3 times the width of the 'bottom'</scene>. This structure is a functional homotetramer of the AMPA-subtype; native ionotropic glutamate receptors are almost exclusively heterotetramers.&nbsp;{{Link Toggle FancyCartoonHighQualityView}}.
 +
 +
'''Domains'''
 +
The subunits themselves are modular <ref>PMID: 7539962</ref>and the major domains are found in layers in the tetrameric structure.
 +
*The 'top' layer is composed of the <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Atd_domain/4'>amino-terminal domain (ATD)</scene>
 +
::This <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Atd_gly/2'>extracellular domain is glycosylated</scene>.
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Lbd_domain/4'>The ligand-binding domain (LBD)</scene> participates directly in agonist/competitive antagonist binding, affects activation gating, and is the portion that forms the 'middle' layer.
 +
::<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Lbd_zk1/2'>The competitive antagonist ZK200775 is bound to the LBD</scene> in the structure.
 +
::The <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Zk1_zoom/1'>ZK200775, a phosphonate quinoxalinedione AMPA antagonist</scene><ref>PMID: 9724812</ref>, was studied as a treatment for stroke because it had demonstrated neuroprotective efficacy in experimental models of stroke and tolerability in healthy volunteers; however, in a multicenter, double-blind, randomized, placebo-controlled phase II trial, it was found to have significant sedative effects in patients with acute stroke which precludes its further development as a neuroprotective agent<ref>PMID: 16131799</ref>.
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Tmd_domain/2'>The transmembrane domain (TMD)</scene> is the portion that forms the membrane-spanning on the 'bottom' of the solved structure.
 +
::To help give a better idea of how the glutamate receptor is oriented on the cell surface in the membrane lipid bilayer, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/3kg2opm_mem/11'>a slab representative of hydrophobic core of the lipid bilayer</scene> as calculated by the [http://opm.phar.umich.edu/protein.php?pdbid=3kg2 Orientations of Proteins in Membranes database] (University of Michigan, USA) is shown with the red patch of spheres indicating the boundary of the hydrophobic core closest to the outside of the cell and the dark blue patch of spheres indicating the boundary closest to the inside of the cell.
 +
::[[Image:Opm_periplasmic_topology.gif]]
 +
* The carboxy-terminal domain that plays a role in both receptor localization and regulation is not seen in the structure but would be below the transmembrane domain as it is cytoplasmic.
 +
 +
'''Domain swapping between the subunits and symmetry mismatch between the domains'''
 +
 +
*Unanticipated is the domain swapping and crossover that occurs between the subunits interactions. In order to discuss the remarkable swapping, it is best to <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Default3kg2letter/4'>designate each subunit with a letter</scene>: <br>&nbsp;&nbsp;&nbsp; '''<span style="color:forestgreen">A</span>'''&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; '''<span style="color:red">B</span>'''&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; '''<span style="color:cornflowerblue">C</span>''' &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; '''D'''
 +
 +
*Considering each chain, there is crossover as the pairs of subunits seen in the ATD are swapped in the LBD.
 +
::In the ATD domain -
 +
::*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Ab_in_atd/1'>Portions of the A and B subunits pair up</scene>.
 +
::*And the <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Cd_in_atd/2'>Portions of the C and D subunits form a pair</scene>.
 +
::*While that is going on, in the ATD there is also inter-pair interactions mediated between <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Abcd_in_atd/2'>subunits B and D</scene>. Note this view really highlights the two-fold symmetry between the A-B and C-D pairs at the level of the ATD.
 +
::In the LBD domain -
 +
::*Whereas in the ATD domain A and B paired up, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Ad_in_lbd/3'>portions of the A and D subunits pair up</scene> in the LBD.
 +
::*And the <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Bc_in_lbd/1'>Portions of the B and C subunits form a pair</scene>.
 +
::*While that is going on, in the LBD there is also extensive inter-pair interactions mediated between <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Abcd_in_lbd/6'>subunits A and C</scene>. Note this view highlights the two-fold symmetry between the A-D and B-C pairs at the level of the LBD. <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Abcd_in_lbdside/1'>Looking from the side helps in seeing the inter-pair interactions between A and C</scene>.
 +
:The domain swapping can be observed from the side following the backbone of each chain as well: <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Swap_full_side/1'>A chain</scene>, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Swap_full_side/2'>B chain</scene>, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Swap_full_side/3'>C chain</scene>, and <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Swap_full_side/5'>D chain</scene>. And <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Default3kg2letter/4'>all for comparison</scene>.
 +
 +
*The <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Tmd_domain_4fold/2'>symmetry is an overall four-fold for the TMD</scene>. Thus, remarkably, the symmetry switches from an overall two-fold symmetry for the ATD and LBD to four-fold for the TMD.
 +
 +
As a result of the swapping and symmetry mismatch, there is subunit non-equivalence; even though all the chains are the same chemically, there are 2 distinct conformations of the subunits. This means there are 2 matching pairs of subunits.
 +
* <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Ac3kg2letter/1'>A is equivalent to C</scene>
 +
* <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Bd3kg2letter/2'>B is equivalent to D</scene>
 +
* <span style="color:forestgreen">Subunit '''A</span>''' is equivalent to <span style="color:cornflowerblue">Subunit '''C'''</span> (in the small structure window in this section). In the main window, a <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Atocmorph/5' target='main2NDwindow'>morph showing the equivalency of the 2 subunits by rotating around the axis of their symmetry</scene>.
 +
* <span style="color:red">Subunit '''B</span>''' is equivalent to Subunit '''D''' (in the small structure window in this section). In the main window, a <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Btodmorph/5' target='main2NDwindow'>morph showing the equivalency of the two subunits by rotating around the axis of their symmetry</scene>.
 +
 +
However, each of the subunit '''<span style="color:forestgreen">A</span>'''/<span style="color:cornflowerblue">'''C'''</span> group though is distinct from those of the <span style="color:red">'''B</span>'''/'''D''' group. Having established the two equivalent groups we can simplify the discussion of the relationship between the two pairs by focusing solely on comparing <span style="color:forestgreen">Subunit '''A'</span>''' and <span style="color:red">Subunit '''B</span>'''.<br>
 +
The domains themselves stay relatively static between the two conformational forms, with the linkers in between and the resulting arrangement changing. This is best illustrated by superposition of the individual domains of <span style="color:forestgreen">Subunit '''A</span>''' and <span style="color:red">Subunit '''B</span>''':
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Atdatobsuper/4' target='main2NDwindow'>Superposition of the ATD</scene>.
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Lbdatobsuper/2' target='main2NDwindow'>Superposition of the LBD</scene>.
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Tmdatobsuper/1' target='main2NDwindow'>Superposition of the TMD</scene>.
 +
 +
<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Atobmorph/2' target='main2NDwindow'>Subunit A morphing into Subunit B best illustrates how portions, especially the linkers, of the protein change</scene> between the two conformational forms.<br>
 +
{{Button Toggle AnimationOnPause}}
 +
:The linkers are key; besides playing roles in domain swapping and resolving the symmetry mismatch, they are also responsible for relaying the modulation signals from the ATD to the other domains and signaling the conformational change of the LBD to control the opening and closing of the pore. Beyond the two conformations seen here though this particular structure ([[3kg2]]) of the receptor does not shed light on the transduction process.
 +
 +
'''Transmembrane domain architecture and the occluded pore'''
 +
 +
*<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Transmemlabeled/1' target='main2NDwindow'>Transmembrane segments M1 to M4 depicted in different colors to show the approximate 4-fold rotational symmetry of the entire ion channel domain.</scene>
 +
::* '''<span style="color:coral">M1</span>'''
 +
::* '''<span style="color:lightgreen">M2</span>'''
 +
::* '''<span style="color:violet">M3</span>'''
 +
::* '''<span style="color:lightskyblue">M4</span>'''
 +
 +
*The segments shown again, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Transmem/4' target='main2NDwindow'>this time parallel to the 4-fold axis</scene>.
 +
::There is <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Transmemclosed/1'>no pore visible in the center</scene> consistent with the channel being in a closed state with the antagonist ZK200775 bound to the LBD.
 +
::It is <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/M3_closed/3' target='main2NDwindow'>the tight helix crossing of specifically the M3 helices</scene> that occludes the channel. [BE PATIENT as a small surface is generated.]
 +
::Note <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/M3_closed_top/1' target='main2NDwindow'>the differences between the conformations of the carboxy-termini ('top') of the subunit A/C and B/D M3 segments</scene>. This is in part is why the symmetry is only approximately four-fold and is one of the several intriguing observations in regard to symmetry for this macromolecule. In fact, the location of 2-fold symmetry at the ends of M3 is just above the portion that spans the membrane and is close to the last region of the structure that doesn't show four-fold symmetry as abruptly below this point everything is 4-fold symmetric.
 +
 +
*To better observe the contributions of each of the membrane segments to the subunit-subunit interactions, <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Trans_surf/4' target='main2NDwindow'>the transmembrane domains of three subunits are shown in a surface representation with the segments M1-M4 of the fourth subunit shown as green cylinders</scene>. <nowiki>[</nowiki>Note: this scene generates a substantial surface which may take about a minute to calculate. Be patient.<nowiki>]</nowiki>
 +
::Note that the M4 segment associates with the ion-channel core of an adjacent subunit.
 +
:{{Link Toggle FancyCartoonHighQualityView}}.
 +
*The TMD domain of the GluA2 receptor shares structural and sequence similarity with the pore region of the potassium (K+), as hinted at by earlier work<ref name ="pot1">PMID: 7539962</ref><ref name ="pot2">PMID: 7761417</ref><ref name ="pot3">PMID: 9525859</ref>. Here the pore region of ''Streptomyces lividans'' potassium channel ([[1bl8]])<scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Gluvspottmd/4' target='main2NDwindow'> superposed with the TMD domain of GluA2</scene>, specifically the <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Gluvspottmdm3/1' target='main2NDwindow'>inner helix of the K+ channel aligned with the M3 segment</scene>. The <scene name='User:Wayne_Decatur/Sandbox_Glutamate_receptor/Gluvspottmdm1/2' target='main2NDwindow'>M1 segment of GluA2 also overlays well with the outer helix</scene> of the K+ channel even though these portions weren't even included in the calculation of the alignment seen here.
=ATP-gated P2X receptor cation channel family=
=ATP-gated P2X receptor cation channel family=
Line 47: Line 119:
'''Inward rectifier KCh:'''
'''Inward rectifier KCh:'''
-
**[[6c3p]], [[6c3o]] - hIRK 11 + SUR1 + ATP + ADP – Cryo EM<br />
+
See [[Potassium channel 3D structures]]
-
**[[6baa]] - hIRK 11 + SUR1 + ATP + diabetes drug – Cryo EM<br />
+
-
**[[3ukm]] – hIRK TWIK-1<br />
+
-
**[[3um7]] – hIRK TRAAK<br />
+
-
**[[4ruf]], [[4rue]] - hIRK TRAAK (mutant)<br />
+
-
**[[4wfh]], [[4wfg]], [[4wfe]], [[4wff]] - hIRK TRAAK + antibody<br />
+
-
**[[4i9w]] - hIRK TRAAK (mutant) + antibody<br />
+
-
**[[6pz9]], [[6pza]], [[5twv]] - rIRK 11 + SUR1 + ATP + diabetes drug – Cryo EM<br />
+
-
**[[1u4f]],[[3agw]] - mIRK 2 cytoplasmic domain<br />
+
-
**[[2xky]] - mIRK 2 cytoplasmic domain - EM<br />
+
-
**[[2gix]], [[3vsq]] - mIRK 2 cytoplasmic domain (mutant)<br />
+
-
**[[2e4f]] - mIRK 2 fragment<br />
+
-
**[[1n9p]], [[1u4e]] - mIRK 1 cytoplasmic domain<br />
+
-
**[[3k6n]] - mIRK 1 cytoplasmic domain (mutant)<br />
+
-
**[[5um4]] - mIRK 3.1 (mutant)<br />
+
-
**[[3at8]], [[3at9]], [[3ata]], [[3atb]], [[3atd]], [[3ate]], [[3atf]], [[3auw]], [[3syo]] - mIRK 3.2<br />
+
-
**[[6xis]], [[6xit]] - mIRK 3.2 – Cryo EM<br />
+
-
**[[3syc]], [[3syp]] - mIRK 3.2 (mutant) <br />
+
-
**[[3sya]] - mIRK 3.2 + PIP2<br />
+
-
**[[3syq]] - mIRK 3.2 (mutant) + PIP2<br />
+
-
**[[4kfm]] - mIRK 3.2 + guanine nucleotide-biding protein<br />
+
-
**[[5wua]], [[5twv]] - mIRK 11 + SUR1 - Cryo EM<br />
+
-
**[[5ywc]], [[5ywb]] - mIRK 11 + SUR1 + ADP – Cryo EM<br />
+
-
**[[5ywa]], [[5yw9]], [[5yw8]] - mIRK 11 + SUR1 + ATP – Cryo EM<br />
+
-
**[[5ykg]], [[5ykf]], [[5yke]], [[6jb1]] - mIRK 11 + SUR1 + ATP + diabetes drug – Cryo EM<br />
+
-
**[[6m85]] – cIRK 2.2<br />
+
-
**[[3spj]], [[6m86]] – cIRK 2.2 (mutant)<br />
+
-
**[[3spc]] – cIRK 2.2 + DGPP <br />
+
-
**[[3spg]], [[3sph]], [[5kum]], [[5kuk]], [[6m84]] – cIRK 2.2 (mutant) + PIP2<br />
+
-
**[[3spi]] – cIRK 2.2 + PIP2<br />
+
-
**[[7cal]] - AtIRK KAT1 – Cryo EM<br />
+
-
**[[1xl4]], [[1xl6]], [[2wlk]], [[2x6a]], [[2x6b]], [[2x6c]], [[6o9u]] - MmIRK KIRBAC3.1<br />
+
-
**[[4lp8]], [[6o9t]], [[6o9v]] - MmIRK KIRBAC3.1 (mutant) <br />
+
-
**[[3zrs]] – MmIRK 10<br />
+
-
**[[1p7b]] - BpIRK C-terminal<br />
+
-
 
+
</StructureSection>
</StructureSection>
==References==
==References==
<references/>
<references/>
 +
[[Category:Topic Page]]

Current revision

The rat glycosylated glutamate receptor in complex with a competitive antagonist (3kg2)

Drag the structure with the mouse to rotate

References

  1. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  2. Moura Barbosa AJ, De Rienzo F, Ramos MJ, Menziani MC. Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors. Eur J Med Chem. 2010 Nov;45(11):4746-60. Epub 2010 Jul 27. PMID:20724042 doi:10.1016/j.ejmech.2010.07.039
  3. Moreira IS, Fernandes PA, Ramos MJ. Computational alanine scanning mutagenesis--an improved methodological approach. J Comput Chem. 2007 Feb;28(3):644-54. PMID:17195156 doi:10.1002/jcc.20566
  4. De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
  5. De Rienzo F, Del Cadia M, Menziani MC. A first step towards the understanding of the 5-HT(3) receptor subunit heterogeneity from a computational point of view. Phys Chem Chem Phys. 2012 Sep 28;14(36):12625-36. Epub 2012 Aug 9. PMID:22880201 doi:10.1039/c2cp41028a
  6. Wo ZG, Oswald RE. Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci. 1995 Apr;18(4):161-8. PMID:7539962
  7. Turski L, Huth A, Sheardown M, McDonald F, Neuhaus R, Schneider HH, Dirnagl U, Wiegand F, Jacobsen P, Ottow E. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10960-5. PMID:9724812
  8. Walters MR, Kaste M, Lees KR, Diener HC, Hommel M, De Keyser J, Steiner H, Versavel M. The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis. 2005;20(5):304-9. Epub 2005 Aug 30. PMID:16131799 doi:10.1159/000087929
  9. Wo ZG, Oswald RE. Unraveling the modular design of glutamate-gated ion channels. Trends Neurosci. 1995 Apr;18(4):161-8. PMID:7539962
  10. Wood MW, VanDongen HM, VanDongen AM. Structural conservation of ion conduction pathways in K channels and glutamate receptors. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4882-6. PMID:7761417
  11. Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998 Apr 3;280(5360):69-77. PMID:9525859

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Personal tools